aidsmap news story
Taking an integrase inhibitor as part of an HIV treatment regimen significantly reduced the risk of a major cardiovascular event or coronary artery disease when compared to other forms of HIV treatment, a study in people with HIV in the United States has found.
The study took place in a cohort of people with HIV who may reflect the reality of HIV care in the United States – racially and ethnically diverse with a history of variable access to health care.
The study findings contradict information from studies in other parts of the world which suggest that integrase inhibitor treatment was associated with a raised risk of major cardiovascular disease.
Read the full news story here.
Source : aidsmap
Related HIV and Co-Infections News
-
TheBodyPro: Frailty is connected to mortality among people with HIV — and the risk starts early
-
[Press release] St. Jude: Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents
-
CATIE: Large and long French study explores changes in cancer risk among people with HIV
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.